* Vaxart Inc VXRT.OQ reported a quarterly adjusted loss
of 23
cents per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 24 cents per share.
* Reported revenue was zero; analysts expected $66.67
thousand.
* Vaxart Inc's reported EPS for the quarter was a loss of 23
cents.
* The mean earnings estimate of analysts had fallen by
about 3.2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Vaxart Inc shares had fallen by 34.4% this quarter and
lost 77.2% so far this year.
* The company reported a quarterly loss of $29.31 million.
* Wall Street's median 12-month price target for Vaxart Inc
is
$7.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
8 at 10:02 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.24 -0.23 Beat
Jun. 30 2022 -0.21 -0.23 Missed
Mar. 31 2022 -0.16 -0.20 Missed
Dec. 31 2021 -0.17 -0.17 Met